These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 24372893)

  • 1. Cost of illness for bipolar disorder: a systematic review of the economic burden.
    Kleine-Budde K; Touil E; Moock J; Bramesfeld A; Kawohl W; Rössler W
    Bipolar Disord; 2014 Jun; 16(4):337-53. PubMed ID: 24372893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-of-illness studies for bipolar disorder: systematic review of international studies.
    Jin H; McCrone P
    Pharmacoeconomics; 2015 Apr; 33(4):341-53. PubMed ID: 25576148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluations of non-pharmacological interventions and cost-of-illness studies in bipolar disorder: A systematic review.
    Kraiss JT; Wijnen B; Kupka RW; Bohlmeijer ET; Lokkerbol J
    J Affect Disord; 2020 Nov; 276():388-401. PubMed ID: 32871669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluations and cost analyses in posttraumatic stress disorder: a systematic review.
    von der Warth R; Dams J; Grochtdreis T; König HH
    Eur J Psychotraumatol; 2020 May; 11(1):1753940. PubMed ID: 33488993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Costs of bipolar disorder.
    Kleinman L; Lowin A; Flood E; Gandhi G; Edgell E; Revicki D
    Pharmacoeconomics; 2003; 21(9):601-22. PubMed ID: 12807364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost of epilepsy: a systematic review.
    Strzelczyk A; Reese JP; Dodel R; Hamer HM
    Pharmacoeconomics; 2008; 26(6):463-76. PubMed ID: 18489198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The economic burden of bipolar I disorder in the United States in 2015.
    Cloutier M; Greene M; Guerin A; Touya M; Wu E
    J Affect Disord; 2018 Jan; 226():45-51. PubMed ID: 28961441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The humanistic and economic burden of systemic lupus erythematosus : a systematic review.
    Meacock R; Dale N; Harrison MJ
    Pharmacoeconomics; 2013 Jan; 31(1):49-61. PubMed ID: 23329592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct, indirect and intangible costs of acute hand and wrist injuries: A systematic review.
    Robinson LS; Sarkies M; Brown T; O'Brien L
    Injury; 2016 Dec; 47(12):2614-2626. PubMed ID: 27751502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Economic Burden of Bipolar Disorder in the United States: A Systematic Literature Review.
    Bessonova L; Ogden K; Doane MJ; O'Sullivan AK; Tohen M
    Clinicoecon Outcomes Res; 2020; 12():481-497. PubMed ID: 32982338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-of-illness studies of depression: a systematic review.
    Luppa M; Heinrich S; Angermeyer MC; König HH; Riedel-Heller SG
    J Affect Disord; 2007 Feb; 98(1-2):29-43. PubMed ID: 16952399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annual cost of bipolar disorder to UK society.
    Das Gupta R; Guest JF
    Br J Psychiatry; 2002 Mar; 180():227-33. PubMed ID: 11872515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The direct and indirect costs associated with endometriosis: a systematic literature review.
    Soliman AM; Yang H; Du EX; Kelley C; Winkel C
    Hum Reprod; 2016 Apr; 31(4):712-22. PubMed ID: 26851604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of hospitalisations and inpatient care costs of manic episodes: in patients with bipolar I disorder in France.
    de Zelicourt M; Dardennes R; Verdoux H; Gandhi G; Khoshnood B; Chomette E; Papatheodorou ML; Edgell ET; Even C; Fagnani F
    Pharmacoeconomics; 2003; 21(15):1081-90. PubMed ID: 14596627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling costs and burden of informal caregiving for persons with bipolar disorder.
    Wolff N; Perlick DA; Kaczynski R; Calabrese J; Nierenberg A; Miklowitz DJ
    J Ment Health Policy Econ; 2006 Jun; 9(2):99-110. PubMed ID: 17007487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost of Lung Cancer: A Systematic Review.
    Yousefi M; Jalilian H; Heydari S; Seyednejad F; Mir N
    Value Health Reg Issues; 2023 Jan; 33():17-26. PubMed ID: 36201970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-of-illness and Economic Evaluation of Interventions in Children and Adolescents With Chronic Pain: A Systematic Review.
    Kitschen A; Wahidie D; Meyer D; Rau LM; Ruhe AK; Wager J; Zernikow B; Sauerland D
    Clin J Pain; 2024 May; 40(5):306-319. PubMed ID: 38268231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Cost of Psoriasis and Psoriatic Arthritis in 5 European Countries: A Systematic Review.
    Burgos-Pol R; Martínez-Sesmero JM; Ventura-Cerdá JM; Elías I; Caloto MT; Casado MÁ
    Actas Dermosifiliogr; 2016 Sep; 107(7):577-90. PubMed ID: 27316590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic evaluations in bipolar disorder: a systematic review and critical appraisal.
    Abdul Pari AA; Simon J; Wolstenholme J; Geddes JR; Goodwin GM
    Bipolar Disord; 2014 Sep; 16(6):557-82. PubMed ID: 24917477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The economic burden of bipolar disease.
    Woods SW
    J Clin Psychiatry; 2000; 61 Supp 13():38-41. PubMed ID: 11153811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.